Scholarlink

Background <p>Production of mitochondrial reactive oxygen species (mROS) induces acinar-to-ductal metaplasia (ADM), an initiating step towards pancreatic ductal adenocarcinoma (PDAC). Manganese superoxide dismutase (SOD2, MnSOD) is the major mitochondrial ROS scavenger and less active SOD2 at the mitochondria increases risk of developing PDAC, indicating clinical relevance of SOD2. However, the role of SOD2 in PDAC tumorigenesis remains elusive.</p> Methods <p>To determine SOD2’s role in PDAC initiation and progression, we crossed <i>Sod2</i><sup><i>fl/fl</i></sup> mice into the p48<sup>Cre</sup>;LSL-<i>Kras</i><sup>G12D</sup> (KC) mouse model. We also utilized mouse primary acinar cells and macrophages for in vitro ADM and ROS assays, and to evaluate initiating events downregulating <i>Sod2</i>. Human expression data and tissue assessed clinical relevance.</p> Results <p>SOD2 is downregulated in low-grade lesions, but knockout alone is insufficient for lesion formation. In conjunction with oncogenic <i>Kras</i>, knockout of <i>Sod2</i> facilitates dysplasia and cancer stem cell formation in the canonical PDAC progression pathway but also increases presence of oxidative stress-resistant atypical flat lesions (AFLs), which are an understudied direct precursor to PDAC.</p> Conclusions <p>Oncogenic Kras suppresses mitohormesis, a process whereby mitochondrial stress upregulates stress-reducing protective responses to enhance cell viability. Inflammatory macrophage signaling decreases <i>Sod2</i> expression, increasing ROS and promoting ADM and canonical PanIN progression or alternatively, compensatory antioxidants GPX4 and NRF1 are upregulated in atypical flat lesions (AFLs), decreasing senescence and lipid peroxidation. With additional inflammation, increased dysplasia results in accelerated tumor formation and the presence of AFL leads to more poorly-differentiated tumor areas. This is of clinical significance, as poorly-differentiated human PDAC has a lower survival rate, and these tumors show less SOD2 expression.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月28日

查看全文
  • Alicia K. Fleming Martinez,
  • Heike R. Döppler,
  • Ryan Argo,
  • Ligia I. Bastea,
  • Brandy H. Edenfield,
  • Irene Espositio,
  • Peter Storz

摘要

Background

Production of mitochondrial reactive oxygen species (mROS) induces acinar-to-ductal metaplasia (ADM), an initiating step towards pancreatic ductal adenocarcinoma (PDAC). Manganese superoxide dismutase (SOD2, MnSOD) is the major mitochondrial ROS scavenger and less active SOD2 at the mitochondria increases risk of developing PDAC, indicating clinical relevance of SOD2. However, the role of SOD2 in PDAC tumorigenesis remains elusive.

Methods

To determine SOD2’s role in PDAC initiation and progression, we crossed Sod2fl/fl mice into the p48Cre;LSL-KrasG12D (KC) mouse model. We also utilized mouse primary acinar cells and macrophages for in vitro ADM and ROS assays, and to evaluate initiating events downregulating Sod2. Human expression data and tissue assessed clinical relevance.

Results

SOD2 is downregulated in low-grade lesions, but knockout alone is insufficient for lesion formation. In conjunction with oncogenic Kras, knockout of Sod2 facilitates dysplasia and cancer stem cell formation in the canonical PDAC progression pathway but also increases presence of oxidative stress-resistant atypical flat lesions (AFLs), which are an understudied direct precursor to PDAC.

Conclusions

Oncogenic Kras suppresses mitohormesis, a process whereby mitochondrial stress upregulates stress-reducing protective responses to enhance cell viability. Inflammatory macrophage signaling decreases Sod2 expression, increasing ROS and promoting ADM and canonical PanIN progression or alternatively, compensatory antioxidants GPX4 and NRF1 are upregulated in atypical flat lesions (AFLs), decreasing senescence and lipid peroxidation. With additional inflammation, increased dysplasia results in accelerated tumor formation and the presence of AFL leads to more poorly-differentiated tumor areas. This is of clinical significance, as poorly-differentiated human PDAC has a lower survival rate, and these tumors show less SOD2 expression.